Apply twice a day to exposed areas, morning and noon. In case of sun exposure, apply half an hour before on dry skin.
In patients receiving pharmacological treatment or surgery for actinic keratosis and other forms of non-melanoma skin cancer, treatment should be started as soon as the lesions are closed.
Application Area: Face, forehead, ears, neckline, bald head and back of the hands. Apply over entire cancerisation field.
Indications: Actinic damage, photoaged skin, immunosuppressed, patients with cancer treatments.
Fluid texture allows for immediate absorption without greasy or white residue. Easy spreadability allows for small amount of product needed per application, making product last longer.
OverviewEryfotona is indicated for the prevention and adjuvant treatment of actinic keratosis and other forms of non-melanoma skin cancer caused by UV-induced DNA damage. It contains DNA Repairsomes™ (Photolyase enzyme) encapsulated in liposomes for effective, fast delivery into the skin where it assists in repairing DNA mutations caused by UV rays. It protects the skin against the damaging effects of the sun with its very high UV protection with SPF99. Eryfotona is clinically proven to visibly reduce AK lesions and prevent their return. It’s fluid texture allows for easy spreadability and immediate absorption. This provides comfort of use and allows for small amounts of the product needed per application, making the product last for a long time.
Specifications
Size
50 ml
Department
Men
Shelf Life
12 month
Model Number
8429420070875
Added to cart
Cart Total 240.00
We're Always Here To Help
Reach out to us through any of these support channels
'`noon`', the 'noon device', 'noon east', 'east' and the 'east device' are trade marks or registered trade marks of Noon AD Holdings LTD. in the UAE and other countries